A Novel Sirna-Based Insulin Sensitizer, Jun 01, Targeting the Integrated Stress Response in Diabetic Mice
DOI:
文献链接:
其他信息:
J Hoekman, C Reddy, M Kaeding…
Metabolism …, 2025
metabolismjournal.com
Despite the advancements in GLP-1 drugs, managing glucose levels effectively remains a challenge. The widely used insulin sensitizer, pioglitazone, has side effects like weight gain and a black box warning for congestive heart failure, highlighting the need for novel insulin-sensitizing treatments.

